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Background: Cytotoxic effects of some of the members of papaveraceae family have been reported in Iranian folk
medicine. Recent reports has indicated that alkaloids fraction of opium may be responsible for its cytotoxic effect;
however, the mechanism of this effect is not fully understood. This study has been designed to investigate the
selective cytotoxic, genotoxic and also apoptosis induction effects of noscapine, papaverine and narceine, three
non-addictable opium alkaloids, on HT29, T47D and HT1080 cancer cell lines. Mouse NIH3T3 cell line was chosen to
present non-cancerous cells and Doxorubicin was selected as the positive control.
Methods: Cells were treated by different concentrations of Noscapine, Papaverine, Narceine and doxorubicin;
viability was assessed by MTT assay. The genotoxicity and apoptosis induction were tested with comet assay and
Annexin-V affinity when the concentration of each these drugs is less than its IC50. In addition, the DNA damage
and caspase activity of the T47D cells were examined and the results were compared.
Results: This study noted the cytotoxicity and genotoxicity of noscapine and papaverine, specifically on cancerous
cell lines. Furthermore, papaverine induces apoptosis in all studied cancer cell lines and noscapine showed this
effect in T47D and HT29 cells but not in NIH-3 T3 cells as noncancerous cell line. narceine also showed genototoxicity
in the studied cell lines at its IC50 concentration.
Conclusions: This experiment suggests that noscapine and papaverine may be of use in cancer treatment due to their
specific cytotoxicity and genotoxicity. However, further in vivo studies are needed to confirm its usefulness in cancer
treatment.
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The agents which have the potential for induction of
apoptosis may be considered as good candidates for can-
cer therapy due to their effect on the uncontrolled prolif-
eration of malignant cells. In spite of excellent anti-tumor
activities of common chemotherapy drugs, treatment will
be restricted in some cases due to drug-resistance, low
therapeutic index, severe side effects and different routes
of administration [1]. Recently, in search for new treat-
ments for cancer, there has been an emphasis on herbal
and natural compounds. Cytotoxic effects of some mem-
bers of Papaveraceae family have been considered in* Correspondence: ostadnas@tums.ac.ir
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unless otherwise stated.Iranian and Indian medicine [2]. Papaverine somniferum
L. (opium poppy) has been traditionally used in Chinese
and Indian herbal medicine to cure some disorders includ-
ing chronic cough, dysentery, diarrhea, rectum prolapse
and gastrointestinal problems [3]. The contents of opium
alkaloids include morphine, codeine, tebaine, noscapine,
papaverine, narceine as well as little percentage of some
other compounds [4]. Many studies revealed a remarkable
anti-tumor activity of the alkaloid noscapine, a naturally-
occurring benzylisoquinoline alkaloid that constitutes
about 2-10% of the alkaloid content of opium [5,6]. Fur-
thermore, the anti-tumor activities of noscapine and its
tubulin-binding property have been mentioned in many
studies [7-12]. Noscapine inhibits the progression of
melanoma, lymphoma, leukemia, breast cancer, colon can-
cer, ovarian carcinoma, glioblastoma, non-small cell lunghis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nificant toxicity to the kidney, heart, liver, bone marrow,
spleen and small intestine [8,12-16]. Papverine and nar-
ceine are two other benzylisoquinoline alkaloids consti-
tuting 0.5-3% and <0.5% of the alkaloid contents of
opium, respectively. Papaverine has been used clinically
as smooth muscle relaxant, anti-spasmodic for gastro-
intestinal disorders, cough suppressant and for treatment
of erectile dysfunction (an unlabeled use). Although
cytotoxic effect of papaverine and some of its derivatives
has been observed in breast cancer, melanoma and pros-
tate cancer [17-20], their mechanism of action has not
been fully understood. Based on our knowledge, no pre-
vious study has examined the anti-cancer activities of
narceine.
In this study three different human cancer cell lines
have been chosen. HT29 colorectal carcinoma and
T47D breast cancer cells as two of the most common
types of human tumors and HT1080 fibrosarcoma cells
as one of the most resistant cell lines to anti-cancer ther-
apy. In addition, non-cancerous NIH-3 T3 cell line has
been chosen to compare the effect of the agents between
cancerous and non-cancerous cells and doxorubicin has
been chosen as positive control. The purpose of this
study is to show whether papaverine and narcein have
selective cytotoxicity, genotoxicity and induction of
apoptosis in cancerous cell lines as has been demon-
strated in noscapine and was claimed in the traditional
medicine.
Methods
Cell lines and chemicals
T47D (Breast, ductal-carcinoma, Human), HT-29 (Colon,
epithelial-like carcinoma, Human), HT-1080 (connective
tissue, fibro sarcoma, Human) and NIH-3 T3 (Swiss mouse
embryo fibroblast) cell lines were all obtain from National
Cell Bank (Pasture institute of Iran, Tehran). The cells
were cultured in RPMI 1640 medium (Biosera, England)
that was supplemented with 10% heat-inactivated fetal bo-
vine serum (FBS; Biosera, England) as well as antibiotic
vials containing 100 U/ml penicillin and 100 μg/ml
streptomycin (Gibco, USA); then were incubated in a hu-
midified atmosphere with 5% CO2 at 37°C.
The materials used in the present study and the manu-
facturers provided them are as following: noscapine
hydrochloride, agarose and low melting point agarose
(LMP) from Sigma-Aldrich (USA), papaverine hydro-
chloride and ethanol from TEMAD Co. (Tehran, Iran),
narceine trihydrate from Seqchem (UK), doxorubicin from
Sobhan-daru (Tehran, Iran), MTT (3-[4,5-dimethylthiazol-
2yl] -2,5-diphenyl tetrazolium bromide) powder and Cas-
pase Assay fluorometric kit from Roche (Germany) and
annexine V-PE apoptosis detection kit from Abcam
(UK).In vitro cytotoxicity assay
The cells in logarithmic phase of growth were seeded
into 96-well plates at a density of 104 cells per well and
allowed to incubate overnight at 37°C. Cells were treated
with different concentrations of noscapine, papaverine,
narceine and doxorubicin and were incubated for 48 hours
and then cell viability was determined by MTT assay.
Briefly, 25 μl of 5 mg/ml MTT solution in phosphate-
buffered saline was added and incubated for four hours at
37°C. The medium was removed and 100 μl dimethylsulf-
oxide (DMSO) was added to each well. The formazan salts
were quantified by reading the absorbance at a test wave-
length of 570 nm and a reference wavelength of 690 nm
[21-23]. The IC50 values were calculated from their cyto-
toxity dose–response curves.Single cell gel electrophoresis (SCGE)/comet
The treated cells were diluted with RPMI 1640 + 10%
FBS to final concentration of 175000 cells/ml. Cells were
treated with 0.4% methanol in the CO2 incubator for
3 hours. Each sample of 50 ul was harvested; then, im-
mediately suspended in 450 μl of solution composed of
10 μl PBS and 75 μl 0.5% LMP agarose. The samples
were then immediately coated on a uniform background
of each rough microscope slide that had been previously
prepared by 1% agarose. The agarose on the microscope
slides was allowed to harden at 4°C for 10 minutes. After
coating with supportive layer (LMP), slides were then
placed in a chilled (4°C) lysis buffer (2.5 M sodium
chloride, 100 mM EDTA, pH = 10, 10 mM Trise base,
1% sodium lauryl sarcosinate, 0.01% triton x-100) for
30 minutes to unwind the nuclear DNA at 4°C and drip
dried. Slides were then immersed in the same buffer for
30 minutes at 24 V and 250 mA at room temperature.
DNA damage was recognized by ethidium bromide and
florescence microscope after neutralizing the gel with
Tris buffer [24-26]. Pictures were captured electronically
with an image analysis system and analyzed for fluores-
cence intensity. DNA damage was evaluated using the
tail length and compared with the control group.Examination of PS exposure
Surface exposure of phosphatidyl serine (PS) by apop-
totic cells was examined according to manufacturer’s
protocol. Briefly, cells were seeded in 6-well plates (3 ×
105 Cells/well) and treated with the agents for 24 hours.
Cells were collected and resuspended in binding buffer
(10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM
CaCl2) then were incubated with Annexin V-FITC and
PI for 15 minutes at room temperature and darkness.
The fluorescent intensity of the cells was measured in
FL1 (for FITC) and FL2 (for PI) using flow cytometry
technique.
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Following drug treatments, 2 × 106 cells were collected
and incubated in lysis buffer in ice for 20 minutes. The
cells were centrifuged at 4°C at 12000 g for 30 minutes
and then the supernatant was extracted after being cen-
trifuged using 1:1 mixture of phenol: chloroform. Two
equivalences of cold ethanol with one-tenth equivalence
of sodium acetate were added; nucleic acid contaminant
was decanted and exposed to water-RNase solution for
30 minutes at 37°C. The samples were electrophoresed
through 1.5% agarose gel that contained ethidium brom-
ide at 5 V for 5 minutes and then the voltage increased
to 100 V for an hour [27].
Caspase activity assay
The caspase activity was investigated based on the
Homogeneous Caspases Assay fluorimetric kit. Accord-
ing to the protocol, the cells were cultured in a “black
microplate with clear bottom” and were treated. Caspase
Substrate in lysis buffer was added and was then incu-
bated at 37°C for 2 hours. The free substrate was deter-
mined fluorimetrically at 521 nm and the activity of
caspases was quantified by a calibration curve.Figure 1 Cytotoxic effects of opium alkaloids and doxorubicin on cell
assay at 570 nm in reference standard at 690 nm. The IC50 values were cal
Sigmaplot software and the results are expressed as Mean ± SD. a: HT29, bStatistical analysis
The results were analyzed using one way ANOVA fol-
lowed by Tukey-Kramer Posttest. The p-value less than
0.05 (p < 0.05) was considered significant.
Any experimental research that is reported in this
manuscript have been approved by ethics committee of
pharmaceutical sciences research center of Tehran Uni-
versity of Medical Sciences.Results
Cytotoxicity of noscapine, papaverine, narceine and
doxorubicin on breast cancer, colorectal carcinoma
and connective tissue fibro sarcoma cell lines and
non-cancerous cell line
The MTT curve showed that noscapine and papaverine
had a dose-dependent cytotoxic effect on T47D, HT-29
and HT-1080 cell lines, with no cytotoxic effect on non-
cancerous NIH-3 T3 cells. Narceine did not show any
toxic effect on the studied cell lines and doxorubicin-
induced cytotoxicity was demonstrated on both cancer-
ous and noncancerous cells. The results are presented in
Figure 1.lines. Cell viability in each treatment group was determined by MTT
culated based on their cytotoxicity dose–response curve using
: T47D, c: HT1080 and d: NIH-3 T3.
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damage
The cells were evaluated with an image analysis system
(CASP Comet assay Software Project) and the results
are expressed in terms of L tail (length of tail) and are
presented in Figure 2. Noscapine and papaverine select-
ively enhanced DNA damage on cancerous cells when
compared with noncancerous cells (p < 0.001). On the
other hand, DNA damage was observed on all the cell
lines after administration of doxorubicin (p < 0.001).
However, narceine induced DNA damage only on HT-
1080 cells.
Effect of noscapine, papaverine, narceine on induction of
apoptosis
Cell membrane asymmetry was investigated by trans-
location of phosphatidylserine to the cell surface inFigure 2 The DNA damage detected in treated cells compared to contr
tail length of comet assay has been shown (Mean ± SD) and p-value has beenorder to determine whether or not apoptosis was the
major mechanism of cell death [28,29]. Based on this
method, the apoptosis percentage has been reported and
was compared with that in the control group (Figure 3).
Results showed that doxorubicin has induced apoptosis
in all the cell lines. However, noscapine and papaverine
have induced apoptosis on HT-29 and T47D without
any significant effect on NIH-3 T3 cell lines. However,
the effects of narceine were different from the other two
alkaloids. Narceine showed no apoptotic effect on the
cell lines.
DNA fragmentation in T47D cells treated by noscapine,
papaverine, narceine and compared to doxorubicin
To further determine if apoptosis was the major mech-
anism of the drug-induced cell death, DNA fragmenta-
tion was investigated in T47D cells. Figure 4 shows clearol group. The concentrations less than IC50 were used for treatment. The
reported. a: HT29, b: T47D, c: HT1080 and d: NIH-3 T3.
Figure 3 The membrane asymmetry comparison between treated cells compared to control group. The concentrations less than IC50
were used for treatment. The percentage of cell population of each quadrant has been shown and the quantitative average of percentage of
apoptotic cells of repeated examinations (Mean ± SD) and p-value has been reported. a: HT29, b: T47D, c: HT1080 and d: NIH-3 T3.
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Figure 4 Internucleosomal fragmentation of T47D cells. The
cells were treated with a: doxorubicin, b: noscapine, c: papaverine
and d: narceine then DNA laddering was measured after 48 hours.
e: negative control and L: Laddering marker are presented in figure
as well.
Figure 5 The activity of caspase-3 after 48 hours incubation of
post-treatment T47D cells. Data are reported as mean ± SD. It is
shown significant increase in caspase 3 activities after treatment by
doxorubicin and noscapine (p < 0.001).
Afzali et al. DARU Journal of Pharmaceutical Sciences  (2015) 23:16 Page 6 of 8DNA fragmentation in cells treated by doxorubicin as
positive control. Noscapine and papaverine induced
DNA fragmentation in smaller sizes which were distin-
guishable from negative control group.
Caspase activity in T47D cells treated by noscapine,
papaverine, narceine and compared to doxorubicin
Caspase-3 activity was measured by the cleavage of the
substrate -Rodamin110- fluorimerically and was quanti-
fied by calibration curve (Figure 5). According to Figure 5
and in opposite to doxorubicin and noscapine, papaver-
ine did not increase caspase activity.
Discussion
The present study noted that noscapine and papaverine
had dose-dependent cytotoxic effects on cancer cell
lines, without any cytotoxic effect on noncancerous
NIH-3 T3 cells. Minor, non-significant increases are vis-
ible in cytotoxicity curves that maybe related to the non-
specific toxicity caused by high concentrations of allthree alkaloids used in this study. Therefore the selective
toxicity observed in the present project as well as the
unselective doxorubicin-induced toxicity could have af-
fected both cancerous and noncancerous cells. To deter-
mine whether or not apoptosis was considered as the
major cell death pathway, the cell lines were examined
by using annexin -V affinity, Comet assay, DNA ladder-
ing and Caspase assay. The annexin V assay has been
widely accepted as a marker of apoptosis. Annexin V, a
calcium-dependent phospholipid-binding protein, binds
to PS residues on the cell membrane that are translo-
cated to the outside of the cell due to apoptosis [28,29].
DNA damage is a hallmark of cell death [30] and alka-
line single cell gel electrophoresis (SCGE) or comet
assay is a very sensitive assay for detection of some kinds
of DNA damage including single strand DNA breakage,
alkaline-labile sites and other damage that generates
DNA breaks [25,30]. Based on the results of this study,
noscapine and papaverine induced DNA damage fol-
lowed by apoptosis on HT-29 and T47D cell lines with-
out significant effect on NIH-3 T3 as a noncancerous
cell line. Apoptotic effect of noscapine was confirmed by
the results of DNA fragmentation and caspase assay. It
should be mentioned that even though many other
studies have previously noted apoptosis induced by
Afzali et al. DARU Journal of Pharmaceutical Sciences  (2015) 23:16 Page 7 of 8noscapine on cancer cells, a limited number of research
has focused on noncancerous cell lines [12,31]. Recently,
noscapine has been recognized as a kinetic stabilizer
compound. Interestingly, noscapine binds to different
site of tubulin when compared to other known tubulin-
binding agents. Additionally, even though noscapine’s
binding to tubulin site is not very strong, it is adequate
enough to arrest the cell cycle [31]. Therefore, this fea-
ture might explain the selective cytotoxicity of nosca-
pine. Based on the results of the present study and in
contrast to noscapine and what was expected, papaver-
ine did not increase caspase activity. Several studies have
shown the apoptotic effect of papaverine [17,19,20,32].
However, a study on human promyelocytic leukemia
HL60 cells declined cytotoxic and apoptotic effects of
this alkaloid [33]. According to the results of DNA dam-
age and apoptotic annexin-V assays, papaverine pro-
duced genotoxicity through induction of apoptosis in
cancer cells. This lack of caspase activity has been also
reported previously by Rubis et al. [20]. The results of
the later study as well as our study may indicate that
caspase-independent apoptosis pathways are involved in
the programmed cell death related to papaverine. Fur-
ther studies seem to be necessary to better clarify the
exact mechanisms of papaverine-dependent apoptosis.
Furthermore, in spite of DNA damage in HT-1080 after
alkaloids treatment (Figure 2), apoptosis was not con-
firmed as a cell death pathway in this cell line. This
contradiction might be related to intracellular repair sys-
tem. However, the effects of narceine were different
from those seen with the other two alkaloids on the cells
in our study. Among the cells tested in this study, only
HT-1080 cells were affected by DNA damage induced by
narceine. However this damage did not result in apop-
tosis. It should be mentioned that all the findings about
narceine were obtained despite the fact that no cytotox-
icity was present when MTT assay was performed. Part
of these findings may be related to other pathways of cell
toxicity or death. However, more studies are needed to
determine anti-tumor activity of narceine.
Conclusion
In the present study, we demonstrated that noscapine
and papaverine inserted selective cytotoxicity effects on
cancer cell lines in comparison to doxorubicin which
showed unselective cytotoxic effects on both malignant
and non-malignant cell lines. This effect may present a
new approach for using non-addictive opium alkaloids
in the treatment of cancer. Further investigations are
needed to clarify and confirm the selective cytotoxic ef-
fects of these alkaloids on other noncancerous cell lines.
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